AbbVie Inc. Dividends Paid
AbbVie Inc. (ABBV) reported Dividends Paid of $6.16 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDividends · last filed 2026-08-03
- AbbVie Inc. payments of dividends for the quarter ending 2026-06-30 was $3.07B, a 5.50% increase year-over-year.
- AbbVie Inc. payments of dividends for the quarter ending 2026-03-31 was $3.09B, a 5.50% increase year-over-year.
- AbbVie Inc. payments of dividends for the quarter ending 2025-12-31 was $2.91B, a 5.78% increase year-over-year.
- AbbVie Inc. payments of dividends for the quarter ending 2025-09-30 was $2.91B, a 5.82% increase year-over-year.
- AbbVie Inc. payments of dividends for fiscal 2025 was $11.66B, a 5.73% increase from fiscal 2024.
- AbbVie Inc. payments of dividends for fiscal 2024 was $11.03B, a 4.61% increase from fiscal 2023.
- AbbVie Inc. payments of dividends for fiscal 2023 was $10.54B, a 4.94% increase from fiscal 2022.
- AbbVie Inc. payments of dividends for fiscal 2022 was $10.04B, a 8.44% increase from fiscal 2021.
| Period end | Payments of Dividends 3 month | Payments of Dividends 6 month | Payments of Dividends 9 month | Payments of Dividends 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.07B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $6.16B 10-Q · filed 2026-08-03 | $9.07B derived: sum of 3 quarters · filed 2026-08-03 | $11.98B derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $3.09B 10-Q · filed 2026-05-08 | $6.00B derived: sum of 2 quarters · filed 2026-05-08 | $8.91B derived: sum of 3 quarters · filed 2026-05-08 | $11.82B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $2.91B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $5.82B derived: sum of 2 quarters · filed 2026-02-20 | $8.73B derived: sum of 3 quarters · filed 2026-08-03 | $11.66B 10-K · filed 2026-02-20 |
| 2025-09-30 | $2.91B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $5.82B derived: sum of 2 quarters · filed 2026-08-03 | $8.75B 10-Q · filed 2025-11-04 | $11.50B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $2.91B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $5.83B 10-Q · filed 2026-08-03 | $8.59B derived: sum of 3 quarters · filed 2026-08-03 | $11.34B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $2.92B 10-Q · filed 2026-05-08 | $5.68B derived: sum of 2 quarters · filed 2026-05-08 | $8.43B derived: sum of 3 quarters · filed 2026-05-08 | $11.18B derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $2.75B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $5.50B derived: sum of 2 quarters · filed 2026-02-20 | $8.25B derived: sum of 3 quarters · filed 2026-02-20 | $11.03B 10-K · filed 2026-02-20 |
| 2024-09-30 | $2.75B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $5.50B derived: sum of 2 quarters · filed 2025-11-04 | $8.27B 10-Q · filed 2025-11-04 | $10.90B derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | $2.75B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $5.52B 10-Q · filed 2025-08-04 | $8.15B derived: sum of 3 quarters · filed 2026-02-20 | $10.78B derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $2.77B 10-Q · filed 2025-05-09 | $5.40B derived: sum of 2 quarters · filed 2026-02-20 | $8.03B derived: sum of 3 quarters · filed 2026-02-20 | $10.65B derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $2.63B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $5.25B derived: sum of 2 quarters · filed 2026-02-20 | $7.88B derived: sum of 3 quarters · filed 2026-02-20 | $10.54B 10-K · filed 2026-02-20 |
| 2023-09-30 | $2.63B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $5.25B derived: sum of 2 quarters · filed 2024-11-04 | $7.91B 10-Q · filed 2024-11-04 | $10.42B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $2.63B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $5.29B 10-Q · filed 2024-08-07 | $7.79B derived: sum of 3 quarters · filed 2025-02-14 | $10.30B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $2.66B 10-Q · filed 2024-05-03 | $5.17B derived: sum of 2 quarters · filed 2025-02-14 | $7.67B derived: sum of 3 quarters · filed 2025-02-14 | $10.18B derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $2.51B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $5.01B derived: sum of 2 quarters · filed 2025-02-14 | $7.52B derived: sum of 3 quarters · filed 2025-02-14 | $10.04B 10-K · filed 2025-02-14 |
| 2022-09-30 | $2.50B derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $5.01B derived: sum of 2 quarters · filed 2023-11-06 | $7.54B 10-Q · filed 2023-11-06 | $9.85B derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $2.51B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $5.03B 10-Q · filed 2023-08-07 | $7.35B derived: sum of 3 quarters · filed 2024-02-20 | $9.66B derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $2.53B 10-Q · filed 2023-05-05 | $4.84B derived: sum of 2 quarters · filed 2024-02-20 | $7.16B derived: sum of 3 quarters · filed 2024-02-20 | $9.46B derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $2.31B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $4.63B derived: sum of 2 quarters · filed 2024-02-20 | $6.94B derived: sum of 3 quarters · filed 2024-02-20 | $9.26B 10-K · filed 2024-02-20 |
| 2021-09-30 | $2.31B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $4.63B derived: sum of 2 quarters · filed 2022-11-04 | $6.95B 10-Q · filed 2022-11-04 | $9.05B derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-06-30 | $2.31B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $4.63B 10-Q · filed 2022-08-04 | $6.73B derived: sum of 3 quarters · filed 2023-02-17 | $8.83B derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-03-31 | $2.32B 10-Q · filed 2022-05-06 | $4.42B derived: sum of 2 quarters · filed 2023-02-17 | $6.52B derived: sum of 3 quarters · filed 2023-02-17 | $8.28B derived: sum of 4 quarters · filed 2023-02-17 |
| 2020-12-31 | $2.10B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $4.20B derived: sum of 2 quarters · filed 2023-02-17 | $5.95B derived: sum of 3 quarters · filed 2023-02-17 | $7.72B 10-K · filed 2023-02-17 |
| 2020-09-30 | $2.10B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $3.85B derived: sum of 2 quarters · filed 2021-11-02 | $5.62B 10-Q · filed 2021-11-02 | $7.21B derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | $1.75B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | $3.52B 10-Q · filed 2021-08-02 | $5.11B derived: sum of 3 quarters · filed 2022-02-18 | $6.70B derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | $1.76B 10-Q · filed 2021-05-07 | $3.36B derived: sum of 2 quarters · filed 2022-02-18 | $4.95B derived: sum of 3 quarters · filed 2022-02-18 | $6.54B derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | $1.59B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $3.19B derived: sum of 2 quarters · filed 2022-02-18 | $4.78B derived: sum of 3 quarters · filed 2022-02-18 | $6.37B 10-K · filed 2022-02-18 |
| 2019-09-30 | $1.59B derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $3.18B derived: sum of 2 quarters · filed 2020-11-04 | $4.77B 10-Q · filed 2020-11-04 | $6.22B derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-06-30 | $1.59B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $3.18B 10-Q · filed 2020-08-04 | $4.63B derived: sum of 3 quarters · filed 2021-02-19 | $6.09B derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-03-31 | $1.59B 10-Q · filed 2020-05-08 | $3.04B derived: sum of 2 quarters · filed 2021-02-19 | $4.50B derived: sum of 3 quarters · filed 2021-02-19 | $6.03B derived: sum of 4 quarters · filed 2021-02-19 |
| 2018-12-31 | $1.45B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $2.91B derived: sum of 2 quarters · filed 2021-02-19 | $4.44B derived: sum of 3 quarters · filed 2021-02-19 | $5.58B 10-K · filed 2021-02-19 |
| 2018-09-30 | $1.46B derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $2.99B derived: sum of 2 quarters · filed 2019-11-06 | $4.13B 10-Q · filed 2019-11-06 | $5.16B derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $1.53B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $2.67B 10-Q · filed 2019-08-05 | $3.70B derived: sum of 3 quarters · filed 2020-02-21 | $4.72B derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $1.14B 10-Q · filed 2019-05-03 | $2.17B derived: sum of 2 quarters · filed 2020-02-21 | $3.19B derived: sum of 3 quarters · filed 2020-02-21 | $4.22B derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | $1.03B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $2.06B derived: sum of 2 quarters · filed 2020-02-21 | $3.08B derived: sum of 3 quarters · filed 2020-02-21 | $4.11B 10-K · filed 2020-02-21 |
| 2017-09-30 | $1.03B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $2.05B derived: sum of 2 quarters · filed 2018-11-07 | $3.08B 10-Q · filed 2018-11-07 | $4.01B derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $1.02B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $2.05B 10-Q · filed 2018-08-07 | $2.98B derived: sum of 3 quarters · filed 2019-02-27 | $3.92B derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $1.03B 10-Q · filed 2018-05-04 | $1.96B derived: sum of 2 quarters · filed 2019-02-27 | $2.89B derived: sum of 3 quarters · filed 2019-02-27 | $3.82B derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $933.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $1.87B derived: sum of 2 quarters · filed 2019-02-27 | $2.79B derived: sum of 3 quarters · filed 2019-02-27 | $3.72B 10-K · filed 2019-02-27 |
| 2016-09-30 | $933.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.86B derived: sum of 2 quarters · filed 2017-11-07 | $2.78B 10-Q · filed 2017-11-07 | $3.62B derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $927.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $1.85B 10-Q · filed 2017-08-07 | $2.69B derived: sum of 3 quarters · filed 2018-02-16 | $3.54B derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $924.00M 10-Q · filed 2017-05-05 | $1.76B derived: sum of 2 quarters · filed 2018-02-16 | $2.61B derived: sum of 3 quarters · filed 2018-02-16 | $3.43B derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $840.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $1.69B derived: sum of 2 quarters · filed 2018-02-16 | $2.51B derived: sum of 3 quarters · filed 2018-02-16 | $3.29B 10-K · filed 2018-02-16 |
| 2015-09-30 | $850.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $1.67B derived: sum of 2 quarters · filed 2016-11-07 | $2.45B 10-Q · filed 2016-11-07 | $3.13B derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $818.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $1.60B 10-Q · filed 2016-08-05 | $2.28B derived: sum of 3 quarters · filed 2017-02-17 | $2.95B derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $786.00M 10-Q · filed 2016-05-06 | $1.46B derived: sum of 2 quarters · filed 2017-02-17 | $2.13B derived: sum of 3 quarters · filed 2017-02-17 | $2.81B derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $674.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $1.35B derived: sum of 2 quarters · filed 2017-02-17 | $2.02B derived: sum of 3 quarters · filed 2017-02-17 | $2.66B 10-K · filed 2017-02-17 |
| 2014-09-30 | $673.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $1.35B derived: sum of 2 quarters · filed 2015-11-06 | $1.99B 10-Q · filed 2015-11-06 | $2.63B derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | $673.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $1.31B 10-Q · filed 2015-08-07 | $1.96B derived: sum of 3 quarters · filed 2016-02-19 | $2.60B derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | $641.00M 10-Q · filed 2015-05-08 | $1.28B derived: sum of 2 quarters · filed 2016-02-19 | $1.92B derived: sum of 3 quarters · filed 2016-02-19 | $2.56B derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | $641.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $1.28B derived: sum of 2 quarters · filed 2016-02-19 | $1.92B derived: sum of 3 quarters · filed 2016-02-19 | $2.56B 10-K · filed 2016-02-19 |
| 2013-09-30 | $640.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $1.28B derived: sum of 2 quarters · filed 2014-11-07 | $1.91B 10-Q · filed 2014-11-07 | |
| 2013-06-30 | $638.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $1.27B 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | $636.00M 10-Q · filed 2014-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |